These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 10592921

  • 1. [Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study].
    Cario H, Stahnke K, Kohne E.
    Klin Padiatr; 1999; 211(6):431-7. PubMed ID: 10592921
    [Abstract] [Full Text] [Related]

  • 2. Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter beta-thalassemia study.
    Cario H, Stahnke K, Sander S, Kohne E.
    Ann Hematol; 2000 Jan; 79(1):7-12. PubMed ID: 10663615
    [Abstract] [Full Text] [Related]

  • 3. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ, Göbel U, Christaras A, Janssen G.
    Klin Padiatr; 2005 Jan; 217(3):120-5. PubMed ID: 15858702
    [Abstract] [Full Text] [Related]

  • 4. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, Tamary H.
    Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
    [Abstract] [Full Text] [Related]

  • 5. Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.
    Gamberini MR, De Sanctis V, Gilli G.
    Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():158-69. PubMed ID: 19337172
    [Abstract] [Full Text] [Related]

  • 6. [Arrhythmia in thalassemia major: evaluation of iron chelating therapy by dynamic ECG].
    Cavallaro L, Meo A, Busà G, Coglitore A, Sergi G, Satullo G, Donato A, Calabrò MP, Miceli M.
    Minerva Cardioangiol; 1993 Oct; 41(7-8):297-301. PubMed ID: 8233011
    [Abstract] [Full Text] [Related]

  • 7. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM, Bakir ML, Saned MS, Kadhim AM, Musallam KM, Taher AT.
    Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.
    Gamberini MR, Fortini M, Gilli G, Testa MR, De Sanctis V.
    J Pediatr Endocrinol Metab; 1998 Jul; 11 Suppl 3():867-9. PubMed ID: 10091159
    [Abstract] [Full Text] [Related]

  • 9. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
    Shamsian BS, Aminasnafi A, Moghadassian H, Gachkar L, Arzanian MT, Alavi S, Esfehani H, Garallahi F, Amini R.
    Pediatr Hematol Oncol; 2008 Sep; 25(6):502-8. PubMed ID: 18728969
    [Abstract] [Full Text] [Related]

  • 10. Treatment and complications of thalassemia major in Guangxi, Southern China.
    Yin XL, Wu ZK, He YY, Zhou TH, Zhou YL, Zhang XH.
    Pediatr Blood Cancer; 2011 Dec 15; 57(7):1174-8. PubMed ID: 21394896
    [Abstract] [Full Text] [Related]

  • 11. Hydroxyurea in the treatment of major beta-thalassemia and importance of genetic screening.
    Alebouyeh M, Moussavi F, Haddad-Deylami H, Vossough P.
    Ann Hematol; 2004 Jul 15; 83(7):430-3. PubMed ID: 14722738
    [Abstract] [Full Text] [Related]

  • 12. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.
    Ladis V, Chouliaras G, Berdousi H, Kanavakis E, Kattamis C.
    Ann N Y Acad Sci; 2005 Jul 15; 1054():445-50. PubMed ID: 16339695
    [Abstract] [Full Text] [Related]

  • 13. High transfusion in children with beta-thalassemia/Hb E: clinical and laboratory assessment of 18 cases.
    Torcharus K, Withayathawornwong W, Sriphaisal T, Krutvacho T, Arnutti P, Suwanasophorn C.
    Southeast Asian J Trop Med Public Health; 1993 Jul 15; 24 Suppl 1():96-9. PubMed ID: 7886617
    [Abstract] [Full Text] [Related]

  • 14. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.
    Gamberini MR, Fortini M, De Sanctis V, Gilli G, Testa MR.
    Pediatr Endocrinol Rev; 2004 Dec 15; 2 Suppl 2():285-91. PubMed ID: 16462713
    [Abstract] [Full Text] [Related]

  • 15. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z.
    Fundam Clin Pharmacol; 2009 Jun 15; 23(3):359-65. PubMed ID: 19453758
    [Abstract] [Full Text] [Related]

  • 16. Cardiac disease in beta-thalassaemia major: Is it reversible?
    Atiq M, Bana M, Ahmed US, Bano S, Yousuf M, Fadoo Z, Khurshid M.
    Singapore Med J; 2006 Aug 15; 47(8):693-6. PubMed ID: 16865210
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major].
    Rodríguez Galindo C, Ortega Aramburu JJ, Alonso JL, Albisu M, Casaldáliga J, Díaz de Heredia C, Olivé T, Bastida P.
    Med Clin (Barc); 1994 May 21; 102(19):721-4. PubMed ID: 8041200
    [Abstract] [Full Text] [Related]

  • 18. Cardiac status in well-treated patients with thalassemia major.
    Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, Joussef J, Mitilineou E, Diamanti-Kandaraki E, Meletis J, Karagiorga M.
    Eur J Haematol; 2004 Nov 21; 73(5):359-66. PubMed ID: 15458515
    [Abstract] [Full Text] [Related]

  • 19. Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients.
    Dehshal MH, Hooghooghi AH, Kebryaeezadeh A, Kheirabadi M, Kazemi S, Nasseh A, Shariftabrizi A, Pasalar P.
    Med Sci Monit; 2007 May 21; 13(5):CR235-9. PubMed ID: 17476196
    [Abstract] [Full Text] [Related]

  • 20. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine.
    Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A.
    Haematologica; 2004 Oct 21; 89(10):1187-93. PubMed ID: 15477202
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.